Abiopharma

News list

(99% Neutral) CORTEXYME, INC. (CRTX) Announces Executive Departure

Full text

News bot Oct. 1, 2025, 9:29 p.m.
📋 CORTEXYME, INC. (CRTX) - Executive Changes

Filing Date: 2022-05-20

Accepted: 2022-05-20 08:15:33

Event Type: Executive Changes
Event Details:
Cortexyme Inc (the company was transformed to Quince Therapeutics (QNCX)) (CRTX) Announces Executive and Board Changes Cortexyme Inc (the company was transformed to Quince Therapeutics (QNCX)) (CRTX) announced changes to its leadership team and board of directors. The change is effective as of May 20, 2022. Executive Changes Details:
Personnel Involved: Executive Officer, Caryn McDowell
👥 Executive & Board Changes:
Personnel Involved: Executive Officer, Caryn McDowell
Effective Dates: May 20, 2022, July 8, 2022, May 19, 2022, March 3, 2022, June 30, 2022
💼 Business Developments:
- Partnership
- Acquisition
- Licensing: Not available
- Regulatory Approval: Not available
- Executive Changes
Structured Data:
- Company Name: Cortexyme Inc (the company was transformed to Quince Therapeutics (QNCX))
- CIK: 0001662774
- Ticker Symbol: CRTX
- Period End Date: 2022-05-19
- Document Type: 8-K